988 related articles for article (PubMed ID: 31271350)
1.
Romera D; Aguilera-Correa JJ; Gadea I; Viñuela-Sandoval L; García-Rodríguez J; Esteban J
J Med Microbiol; 2019 Sep; 68(9):1353-1358. PubMed ID: 31271350
[No Abstract] [Full Text] [Related]
2. Activities of nine antifungal agents against Candida auris biofilms.
Chatzimoschou A; Giampani A; Meis JF; Roilides E
Mycoses; 2021 Apr; 64(4):381-384. PubMed ID: 33270284
[TBL] [Abstract][Full Text] [Related]
3. Candida and candidaemia. Susceptibility and epidemiology.
Arendrup MC
Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
[TBL] [Abstract][Full Text] [Related]
4. The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation.
Larkin E; Hager C; Chandra J; Mukherjee PK; Retuerto M; Salem I; Long L; Isham N; Kovanda L; Borroto-Esoda K; Wring S; Angulo D; Ghannoum M
Antimicrob Agents Chemother; 2017 May; 61(5):. PubMed ID: 28223375
[No Abstract] [Full Text] [Related]
5. In vitro activity of micafungin against biofilms of Candida albicans, Candida glabrata, and Candida parapsilosis at different stages of maturation.
Prażyńska M; Bogiel T; Gospodarek-Komkowska E
Folia Microbiol (Praha); 2018 Mar; 63(2):209-216. PubMed ID: 28983822
[TBL] [Abstract][Full Text] [Related]
6. Ceragenins are active against drug-resistant Candida auris clinical isolates in planktonic and biofilm forms.
Hashemi MM; Rovig J; Holden BS; Taylor MF; Weber S; Wilson J; Hilton B; Zaugg AL; Ellis SW; Yost CD; Finnegan PM; Kistler CK; Berkow EL; Deng S; Lockhart SR; Peterson M; Savage PB
J Antimicrob Chemother; 2018 Jun; 73(6):1537-1545. PubMed ID: 29635279
[TBL] [Abstract][Full Text] [Related]
7. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins.
Kuhn DM; George T; Chandra J; Mukherjee PK; Ghannoum MA
Antimicrob Agents Chemother; 2002 Jun; 46(6):1773-80. PubMed ID: 12019089
[TBL] [Abstract][Full Text] [Related]
8. Pore-forming peptide C14R exhibits potent antifungal activity against clinical isolates of
Vélez N; Argel A; Kissmann AK; Alpízar-Pedraza D; Escandón P; Rosenau F; Ständker L; Firacative C
Front Cell Infect Microbiol; 2024; 14():1389020. PubMed ID: 38601736
[TBL] [Abstract][Full Text] [Related]
9. A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance.
Chowdhary A; Prakash A; Sharma C; Kordalewska M; Kumar A; Sarma S; Tarai B; Singh A; Upadhyaya G; Upadhyay S; Yadav P; Singh PK; Khillan V; Sachdeva N; Perlin DS; Meis JF
J Antimicrob Chemother; 2018 Apr; 73(4):891-899. PubMed ID: 29325167
[TBL] [Abstract][Full Text] [Related]
10. Activity of anti-CR3-RP polyclonal antibody against biofilms formed by Candida auris, a multidrug-resistant emerging fungal pathogen.
Dekkerová J; Lopez-Ribot JL; Bujdáková H
Eur J Clin Microbiol Infect Dis; 2019 Jan; 38(1):101-108. PubMed ID: 30327897
[TBL] [Abstract][Full Text] [Related]
11. Abrogation of pathogenic attributes in drug resistant Candida auris strains by farnesol.
Srivastava V; Ahmad A
PLoS One; 2020; 15(5):e0233102. PubMed ID: 32392266
[TBL] [Abstract][Full Text] [Related]
12. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
[No Abstract] [Full Text] [Related]
13. Micafungin triggers caspase-dependent apoptosis in Candida albicans and Candida parapsilosis biofilms, including caspofungin non-susceptible isolates.
Shirazi F; Kontoyiannis DP
Virulence; 2015; 6(4):385-94. PubMed ID: 26065323
[TBL] [Abstract][Full Text] [Related]
14. Candida auris: A pathogen difficult to identify, treat, and eradicate and its characteristics in Japanese strains.
Iguchi S; Itakura Y; Yoshida A; Kamada K; Mizushima R; Arai Y; Uzawa Y; Kikuchi K
J Infect Chemother; 2019 Oct; 25(10):743-749. PubMed ID: 31257156
[TBL] [Abstract][Full Text] [Related]
15. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
Cocuaud C; Rodier MH; Daniault G; Imbert C
J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
[TBL] [Abstract][Full Text] [Related]
16. Candida auris in various hospitals across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs.
Ahmad S; Khan Z; Al-Sweih N; Alfouzan W; Joseph L
Mycoses; 2020 Jan; 63(1):104-112. PubMed ID: 31618799
[TBL] [Abstract][Full Text] [Related]
17. Increasing Susceptibility of Drug-Resistant
Sharafutdinov IS; Ozhegov GD; Sabirova AE; Novikova VV; Lisovskaya SA; Khabibrakhmanova AM; Kurbangalieva AR; Bogachev MI; Kayumov AR
Molecules; 2020 Feb; 25(3):. PubMed ID: 32024254
[TBL] [Abstract][Full Text] [Related]
18. [Comparison of two different methods for the investigation of in vitro susceptibilities of planktonic and biofilm forming Candida species to antifungal agents].
Kaynak Onurdağ F; Ozgen S; Abbasoğlu U; Gürcan IS
Mikrobiyol Bul; 2010 Oct; 44(4):619-31. PubMed ID: 21063974
[TBL] [Abstract][Full Text] [Related]
19.
Černáková L; Roudbary M; Brás S; Tafaj S; Rodrigues CF
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922907
[No Abstract] [Full Text] [Related]
20.
O'Brien B; Chaturvedi S; Chaturvedi V
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31932367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]